Thomas G J, Jenner L, Mason R M, Davies M
Department of Medicine, University of Wales College of Medicine, Royal Infirmary, Cardiff, United Kingdom.
Arch Biochem Biophys. 1990 Apr;278(1):11-20. doi: 10.1016/0003-9861(90)90224-m.
Proteoglycans synthesized by cultures of human glomerular epithelial cells have been isolated and characterized. Three types of heparan sulfate were detected. Heparan sulfate proteoglycan I (HSPG-I; Kav 6B 0.04) was found in the cell layer and medium and accounted for 12% of the total proteoglycans synthesized. HSPG-II (Kav 6B 0.25) accounted for 18% of the proteoglycans and was located in the medium and cell layer. A third population (9% of the proteoglycan population), heparan sulfate glycosaminoglycan (HS-GAG; Kav 6B 0.4-0.8), had properties consistent with single glycosaminoglycan chains or their fragments and was found only in the cell layer. HSPG-I and HSPG-II from the cell layer had hydrophobic properties; they were released from the cell layer by mild trypsin treatment. HS-GAG lacked these properties, consisted of low-molecular-mass heparan sulfate oligosaccharides, and were intracellular. HSPG-I and -II released to the medium lacked hydrophobic properties. The cells also produced three distinct types of chondroitin sulfates. The major species, chondroitin sulfate proteoglycan I (CSPG-I) eluted in the excluded volume of a Sepharose CL-6B column, accounted for 30% of the proteoglycans detected, and was found in both the cell layer and medium. Cell layer CSPG-I bound to octyl-Sepharose. It was released from the cell layer by mild trypsin treatment. CSPG-II (Kav 6B 0.1-0.23) accounted for 10% of the total 35S-labeled macromolecules and was found predominantly in the culture medium. A small amount of CS-GAG (Kav 6B 0.25-0.6) is present in the cell extract and like HS-GAG is intracellular. Pulse-chase experiments indicated that HSPG-I and -II and CSPG-I and -II are lost from the cell layer either by direct release into the medium or by internalization where they are metabolized to single glycosaminoglycan chains and subsequently to inorganic sulfate.
已对人肾小球上皮细胞培养物合成的蛋白聚糖进行了分离和表征。检测到三种硫酸乙酰肝素。硫酸乙酰肝素蛋白聚糖I(HSPG-I;Kav 6B 0.04)存在于细胞层和培养基中,占合成的总蛋白聚糖的12%。HSPG-II(Kav 6B 0.25)占蛋白聚糖的18%,位于培养基和细胞层中。第三种类型(占蛋白聚糖群体的9%),硫酸乙酰肝素糖胺聚糖(HS-GAG;Kav 6B 0.4 - 0.8),其性质与单糖胺聚糖链或其片段一致,仅存在于细胞层中。细胞层中的HSPG-I和HSPG-II具有疏水特性;通过温和的胰蛋白酶处理可将它们从细胞层中释放出来。HS-GAG缺乏这些特性,由低分子量的硫酸乙酰肝素寡糖组成,且存在于细胞内。释放到培养基中的HSPG-I和-II缺乏疏水特性。这些细胞还产生了三种不同类型的硫酸软骨素。主要类型,硫酸软骨素蛋白聚糖I(CSPG-I)在Sepharose CL-6B柱的排阻体积中洗脱,占检测到的蛋白聚糖的30%,在细胞层和培养基中均有发现。细胞层CSPG-I与辛基琼脂糖结合。通过温和的胰蛋白酶处理可将其从细胞层中释放出来。CSPG-II(Kav 6B 0.1 - 0.23)占总35S标记大分子的10%,主要存在于培养基中。细胞提取物中存在少量的CS-GAG(Kav 6B 0.25 - 0.6),与HS-GAG一样存在于细胞内。脉冲追踪实验表明,HSPG-I和-II以及CSPG-I和-II从细胞层中消失,要么是直接释放到培养基中,要么是通过内化作用,在那里它们被代谢为单糖胺聚糖链,随后代谢为无机硫酸盐。